Bilanges, Benoit
Alliouachene, Samira
Pearce, Wayne
Morelli, Daniele
Szabadkai, Gyorgy http://orcid.org/0000-0002-3006-3577
Chung, Yuen-Li
Chicanne, Gaƫtan
Valet, Colin
Hill, Julia M.
Voshol, Peter J.
Collinson, Lucy
Peddie, Christopher
Ali, Khaled
Ghazaly, Essam http://orcid.org/0000-0003-4368-8565
Rajeeve, Vinothini
Trichas, Georgios
Srinivas, Shankar
Chaussade, Claire
Salamon, Rachel S.
Backer, Jonathan M.
Scudamore, Cheryl L.
Whitehead, Maria A.
Keaney, Erin P.
Murphy, Leon O.
Semple, Robert K.
Payrastre, Bernard
Tooze, Sharon A.
Vanhaesebroeck, Bart
Article History
Received: 28 December 2016
Accepted: 30 October 2017
First Online: 27 November 2017
Competing interests
: B.V. is consultant to Karus Therapeutics (Oxford, UK). L.M. was an employee of Novartis who has developed vps34 inhibitors. The remaining authors declare no competing financial interests.